<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, infection prevention and control guidelines and recommendation, Updating the Guideline Methodology, Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, BSI guidelines, Norovirus guidelines, Guideline for Prevention of Catheter-associated Urinary Tract Infections, UTI guidelines, Guideline for Disinfection and Sterilization in Healthcare Facilities, Disinfection and Sterilization Guidelines, Guideline for Isolation Precautions, Guideline for Hand Hygiene in Healthcare Settings, Guidance on Public Reporting of HAIs, Guideline for Preventing Healthcare-Associated Pneumonia, Guideline for the Prevention of Surgical Site Infection, SSI Guidelines, Management of Multidrug-Resistant Organisms In Healthcare Settings, MDRO, Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities, Guideline for Infection Control in Hospital Personnel,  Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program, Immunization of Health-Care Workers: Recommendations of ACIP and HICPAC, HICPAC current roster, healthcare, health departments, healthcare providers, antimicrobial, antibiotic-resistant, pathogens, Coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus species, Candida species, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Acinetobacter baumannii, Klebsiella oxytoca, multidrug-resistant, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci (VRE) faecium, Carbapenem-resistant P. aeruginosa, Extended-spectrum cephalosporin-resistant K. pneumoniae, Carbapenem-resistant A. baumannii, VISA/VERS, Acinetobacter, Burkholderia cepacia, Clostridium sordellii, CDAD, CDI, Enterobacteriaceae (Carbapenem-resistance),Hepatitis, Klebsiella, MRSA, Mycobacterium abscessus, Norovirus, Staphylococcus aureus, Tuberculosis (TB),Vancomycin-intermediate Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Surgical Site Infection (SSI), Ventilator-associated Pneumonia (VAP), Ambulatory Settings, Ambulatory surgical centers, Dialysis Setting, Long-term care facilities (LTCFs), LTC " />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<!-- InstanceEndEditable -->
<meta name="template.version" content="2.5.2" />
<!-- @package: TemplatePackage 'B' @version: "2.5.2" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - Guideline for Prevention of Catheter-associated Urinary Tract Infections, 2009 - HICPAC</title>
<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="004_SSI.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="004_SSI.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="004_SSI.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="004_SSI.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="004_SSI.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="content">
			<div id="content-inner">
				
				<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
				<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" -->
				<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="003_SSI.html">Microbiology</a></li>
                <li><a href="004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="006_SSI.html">SSI Surveillance </a></li>
                <li><a href="007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="ref-SSI.html">References </a></li>
                <li><a href="figure-SSI.html">Figure</a></li>
                <li><a href="table1-SSI.html">Table 1</a></li>
                <li><a href="table2-SSI.html">Table 2</a></li>
                <li><a href="table3-SSI.html">Table 3</a></li>
                <li><a href="table4-SSI.html">Table 4</a></li>
                <li><a href="table5-SSI.html">Table 5</a></li>
                <li><a href="table6-SSI.html">Table 6</a></li>
                <li><a href="table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
				</div>
				
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
				<div id="content-main">
					<div class="main-inner">
						
						<!-- InstanceBeginEditable name="content-main" -->
					 <h1>Guideline for Prevention of Surgical Site Infection, 1999 </h1>
					
                      <div class="module">
                     <p>Download the complete PDF version <a href="https://www.cdc.gov/hicpac/pdf/guidelines/SSI_1999.pdf" >Guideline for Prevention of Surgical Site Infection, 1999 [PDF - 217 KB]</a>.                      </p>
                     </div>
                    
                    <div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">

<ul>
 <li><a href="004_SSI.html#IE2a">Preoperative antiseptic showering</a></li>
  <li><a href="004_SSI.html#IE2b">Preoperative hair removal</a></li>
  <li><a href="004_SSI.html#IE2c">Patient skin preparation in the operating room</a> </li>
  <li><a href="004_SSI.html#IE2d">Preoperative hand/forearm antisepsis</a></li>
   <li><a href="004_SSI.html#IE2e">Management of infected or colonized surgical personnel</a></li>
  <li><a href="004_SSI.html#IE2f">Antimicrobial prophylaxis</a></li>
                               </ul> 

</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

                    
                     <h2 id="IE2"><em>2. Operative characteristics: Preoperative issues</em></h2>
                    
                     
                     <h3 id="IE2a">a. Preoperative antiseptic showering                       </h3>
                     <p>A preoperative antiseptic shower or bath decreases
skin microbial colony counts. In a study of &gt;700 patients
who received two preoperative antiseptic showers,
chlorhexidine reduced bacterial colony counts ninefold
(2.8&times;10<sup>2</sup> to 0.3), while povidone-iodine or triclocarbanmedicated
soap reduced colony counts by 1.3- and 1.9-fold,
respectively.[155] Other studies corroborate these findings.
[156,157] Chlorhexidine gluconate-containing products
require several applications to attain maximum antimicrobial
benefit, so repeated antiseptic showers are usually indicated.
[158] Even though preoperative showers reduce the
skin’s microbial colony counts, they have not definitively
been shown to reduce SSI rates.[159-165]</p>
                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
                     <h3 id="IE2b">b. Preoperative hair removal</h3>
                     
                     <p>Preoperative shaving of the surgical site the night
before an operation is associated with a significantly higher
SSI risk than either the use of depilatory agents or no
hair removal.[16,100,166-169] In one study, SSI rates were 5.6% in
patients who had hair removed by razor shave compared to
a 0.6% rate among those who had hair removed by depilatory
or who had no hair removed.[166] The increased SSI risk
associated with shaving has been attributed to microscopic
cuts in the skin that later serve as foci for bacterial multiplication. Shaving immediately before the operation compared
to shaving within 24 hours preoperatively was associated
with decreased SSI rates (3.1% vs 7.1%); if shaving
was performed &gt;24 hours prior to operation, the SSI rate
exceeded 20%.[166] Clipping hair immediately before an operation
also has been associated with a lower risk of SSI than
shaving or clipping the night before an operation (SSI rates
immediately before = 1.8% vs night before = 4.0%).[170-173]
Although the use of depilatories has been associated with a
lower SSI risk than shaving or clipping,[166,167] depilatories
sometimes produce hypersensitivity reactions.[166] Other
studies showed that preoperative hair removal by any
means was associated with increased SSI rates and suggested
that no hair be removed.[100,174,175] </p>
                     
                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
                     <h3 id="IE2c">c. Patient skin preparation in the operating room</h3>
                     <p>Several antiseptic agents are available for preoperative
preparation of skin at the incision site (<a href="table6-SSI.html">Table 6</a>). The
iodophors (e.g., povidone-iodine), alcohol-containing products,
and chlorhexidine gluconate are the most commonly
used agents. No studies have adequately assessed the comparative
effects of these preoperative skin antiseptics on
SSI risk in well-controlled, operation-specific studies.</p>
<p>
Alcohol is defined by the FDA as having one of the
following active ingredients: ethyl alcohol, 60% to 95% by
volume in an aqueous solution, or isopropyl alcohol, 50% to
91.3% by volume in an aqueous solution.[12] Alcohol is readily
available, inexpensive, and remains the most effective
and rapid-acting skin antiseptic.[176] Aqueous 70% to 92% alcohol
solutions have germicidal activity against bacteria,
fungi, and viruses, but spores can be resistant.[176,177] One
potential disadvantage of the use of alcohol in the operating
room is its flammability.[176-178]</p>
<p>
Both chlorhexidine gluconate and iodophors have
broad spectra of antimicrobial activity.[177,179-181] In some
comparisons of the two antiseptics when used as preoperative
hand scrubs, chlorhexidine gluconate achieved greater
reductions in skin microflora than did povidone-iodine and also had greater residual activity after a single application.
[182-184] Further, chlorhexidine gluconate is not inactivated
by blood or serum proteins.[176,179,185,186] Iodophors may
be inactivated by blood or serum proteins, but exert a bacteriostatic
effect as long as they are present on the
skin.[178,179]</p>
<p>
Before the skin preparation of a patient is initiated,
the skin should be free of gross contamination (i.e., dirt,
soil, or any other debris).187 The patient’s skin is prepared
by applying an antiseptic in concentric circles, beginning in
the area of the proposed incision. The prepared area
should be large enough to extend the incision or create
new incisions or drain sites, if necessary.[1,177,187] The application
of the skin preparation may need to be modified,
depending on the condition of the skin (e.g., burns) or location
of the incision site (e.g., face).</p>
<p>
There are reports of modifications to the procedure
for preoperative skin preparation which include: (1) removing
or wiping off the skin preparation antiseptic agent after
application, (2) using an antiseptic-impregnated adhesive
drape, (3) merely painting the skin with an antiseptic in lieu
of the skin preparation procedure described above, or (4)
using a &quot;clean&quot; versus a &quot;sterile&quot; surgical skin preparation
kit.[188-191] However, none of these modifications has been
shown to represent an advantage.</p>

                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
                     
                     <h3 id="IE2d">d. Preoperative hand/forearm antisepsis                       </h3>
                     <p>Members of the surgical team who have direct contact
with the sterile operating field or sterile instruments or
supplies used in the field wash their hands and forearms by
performing a traditional procedure known as scrubbing (or
the surgical scrub) immediately before donning sterile
gowns and gloves. Ideally, the optimum antiseptic used for
the scrub should have a broad spectrum of activity, be fastacting,
and have a persistent effect.[1,192,193] Antiseptic agents
commercially available in the United States for this purpose
contain alcohol, chlorhexidine, iodine/iodophors, parachloro-
meta-xylenol, or triclosan (<a href="table6-SSI.html">Table 6</a>).[176,177,179,194,195]
Alcohol is considered the gold standard for surgical hand
preparation in several European countries.[196-199] Alcohol containing
products are used less frequently in the United
States than in Europe, possibly because of concerns about
flammability and skin irritation. Povidone-iodine and
chlorhexidine gluconate are the current agents of choice
for most U.S. surgical team members.[177] However, when
7.5% povidone-iodine or 4% chlorhexidine gluconate was
compared to alcoholic chlorhexidine (60% isopropanol and
0.5% chlorhexidine gluconate in 70% isopropanol), alcoholic
chlorhexidine was found to have greater residual antimicrobial
activity.[200,201] No agent is ideal for every situation,
and a major factor, aside from the efficacy of any product,
is its acceptability by operating room personnel after
repeated use. Unfortunately, most studies evaluating surgical
scrub antiseptics have focused on measuring hand bacterial
colony counts. No clinical trials have evaluated the
impact of scrub agent choice on SSI risk.[195,202-206]</p>
<p>
Factors other than the choice of antiseptic agent
influence the effectiveness of the surgical scrub. Scrubbing
technique, the duration of the scrub, the condition of the
hands, or the techniques used for drying and gloving are
examples of such factors. Recent studies suggest that
scrubbing for at least 2 minutes is as effective as the traditional
10-minute scrub in reducing hand bacterial colony
counts,[207-211] but the optimum duration of scrubbing is not
known. The first scrub of the day should include a thorough
cleaning underneath fingernails (usually with a
brush).[180,194,212] It is not clear that such cleaning is a necessary
part of subsequent scrubs during the day. After performing
the surgical scrub, hands should be kept up and
away from the body (elbows in flexed position) so that
water runs from the tips of the fingers toward the elbows.
Sterile towels should be used for drying the hands and
forearms before the donning of a sterile gown and
gloves.[212]</p>
<p>
A surgical team member who wears artificial nails
may have increased bacterial and fungal colonization of
the hands despite performing an adequate hand
scrub.[212,213] Hand carriage of gram-negative organisms has
been shown to be greater among wearers of artificial nails
than among non-wearers.[213] An outbreak of <em>Serratia
marcescens</em> SSIs in cardiovascular surgery patients was
found to be associated with a surgical nurse who wore artificial
nails.[214] While the relationship between nail length
and SSI risk is unknown, long nails—artificial or natural—
may be associated with tears in surgical gloves.[177,180,212]
The relationship between the wearing of nail polish or jewelry
by surgical team members and SSI risk has not been
adequately studied.[194,212,215-217]</p>

                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
                     
                     <h3 id="IE2e">e. Management of infected or colonized surgical personnel                       </h3>
                     <p>Surgical personnel who have active infections or are
colonized with certain microorganisms have been linked to
outbreaks or clusters of SSIs.[33,34,76,218-237] Thus, it is important
that healthcare organizations implement policies to
prevent transmission of microorganisms from personnel to
patients. These policies should address management of jobrelated
illnesses, provision of postexposure prophylaxis
after job-related exposures and, when necessary, exclusion
of ill personnel from work or patient contact. While work
exclusion policies should be enforceable and include a
statement of authority to exclude ill personnel, they should
also be designed to encourage personnel to report their illnesses
and exposures and not penalize personnel with loss
of wages, benefits, or job status.[238]</p>
                     
                     
                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
                     <h3 id="IE2f">f. Antimicrobial prophylaxis</h3>
                     
                     <p>Surgical antimicrobial prophylaxis (AMP) refers to a
very brief course of an antimicrobial agent initiated just
before an operation begins.[239-265] AMP is not an attempt to
sterilize tissues, but a critically timed adjunct used to
reduce the microbial burden of intraoperative contamination
to a level that cannot overwhelm host defenses. AMP
does not pertain to prevention of SSI caused by postoperative
contamination.[265] Intravenous infusion is the mode of
AMP delivery used most often in modern surgical practice.
[20,26,242,266-281] Essentially all confirmed AMP indications
pertain to elective operations in which skin incisions are
closed in the operating room. </p>
                     <p>Four principles must be followed to maximize the
                       benefits of AMP:                       </p>
                     <ul>
                       <li>Use an AMP agent for all operations or classes of
                         operations in which its use has been shown to reduce SSI
                         rates based on evidence from clinical trials or for those
                         operations after which incisional or organ/space SSI would
                         represent a catastrophe.[266,268,269,282-284]                         </li>
                       <li>Use an AMP agent that is safe, inexpensive, and
                         bactericidal with an in vitro spectrum that covers the most
                         probable intraoperative contaminants for the operation.</li>
                       <li>Time the infusion of the initial dose of antimicrobial
                         agent so that a bactericidal concentration of the drug is
                         established in serum and tissues by the time the skin is
                         incised.[285]                         </li>
                       <li>Maintain therapeutic levels of the antimicrobial
                         agent in both serum and tissues throughout the operation
                         and until, at most, a few hours after the incision is closed in
                         the operating room.[179,266-268,282,284,286] Because clotted blood
                         is present in all surgical wounds, therapeutic serum levels
                         of AMP agents are logically important in addition to therapeutic
                         tissue levels. Fibrin-enmeshed bacteria may be
                         resistant to phagocytosis or to contact with antimicrobial
                         agents that diffuse from the wound space. </li>
                     </ul>
                     <p><a href="table4-SSI.html">Table 4</a> summarizes typical SSI pathogens according
                       to operation type and cites studies that establish AMP efficacy
                       for these operations. A simple way to organize AMP
                       indications is based on using the surgical wound classification
                       scheme shown in <a href="table7-8-9-10-SSI.html">Table 7</a>, which employs descriptive
                       case features to postoperatively grade the degree of intraoperative
                       microbial contamination. A surgeon makes the decision
                       to use AMP by anticipating preoperatively the surgical
                       wound class for a given operation.                       </p>
                     <p>AMP is indicated for all operations that entail entry
                       into a hollow viscus under controlled conditions. The most
                       frequent SSI pathogens for such clean-contaminated operations
                       are listed in <a href="table4-SSI.html">Table 4</a>. Certain clean-contaminated operations,
                       such as elective colon resection, low anterior resection
                       of the rectum, and abdominoperineal resection of the
                       rectum, also require an additional preoperative protective
                       maneuver called &quot;preparation of the colon,&quot; to empty the
                       bowel of its contents and to reduce the levels of live microorganisms.
                       [200,239,256,268,284,287] This maneuver includes the administration
                       of enemas and cathartic agents followed by the oral
                       administration of nonabsorbable antimicrobial agents in
                       divided doses the day before the operation.[200,288,289]                       </p>
                     <p>AMP is sometimes indicated for operations that
                       entail incisions through normal tissue and in which no viscus
                       is entered and no inflammation or infection is encountered.
                       Two well-recognized AMP indications for such clean
                       operations are: (1) when any intravascular prosthetic material
                       or a prosthetic joint will be inserted, and (2) for any
                       operation in which an incisional or organ/space SSI would
                       pose catastrophic risk. Examples are all cardiac operations,
                       including cardiac pacemaker placement,[290] vascular operations
                       involving prosthetic arterial graft placement at any
                       site or the revascularization of the lower extremity, and
                       most neurosurgical operations (<a href="table4-SSI.html">Table 4</a>). Some have advocated
                       use of AMP during all operations on the
                       breast.[80,242,264]                       </p>
                     <p>By definition, AMP is not indicated for an operation
                       classified in <a href="table7-8-9-10-SSI.html">Table 7</a> as contaminated or dirty. In such operations,
                       patients are frequently receiving therapeutic antimicrobial
                       agents perioperatively for established infections.                       </p>
                     <p>Cephalosporins are the most thoroughly studied
                       AMP agents.[284] These drugs are effective against many
                       gram-positive and gram-negative microorganisms. They
                       also share the features of demonstrated safety, acceptable
                       pharmacokinetics, and a reasonable cost per dose.[242] In
                       particular, cefazolin is widely used and generally viewed as
                       the AMP agent of first choice for clean operations.[266] If a
                       patient is unable to receive a cephalosporin because of penicillin
                       allergy, an alternative for gram-positive bacterial coverage
                       is either clindamycin or vancomycin.                       </p>
                     <p>Cefazolin provides adequate coverage for many
                       clean-contaminated operations,[268,291] but AMP for operations
                       on the distal intestinal tract mandates use of an agent
                       such as cefoxitin (or some other second-generation
                       cephalosporin) that provides anaerobic coverage. If a
                       patient cannot safely receive a cephalosporin because of
                       allergy, a reasonable alternative for gram-negative coverage is aztreonam. However, an agent such as clindamycin
                       or metronidazole should also be included to ensure anaerobic
                       coverage.</p>
                     <p> The aminoglycosides are seldom recommended as
                       first choices for AMP, either as single drugs or as components
                       of combination regimens.[242,264] References cited in
                       <a href="table4-SSI.html">Table 4</a> provide many details regarding AMP choices and
                       dosages, antimicrobial spectra and properties, and other
                       practical clinical information.                       </p>
                     <p>The routine use of vancomycin in AMP is not recommended
                       for any kind of operation.[242,266,283,292] However, vancomycin
                       may be the AMP agent of choice in certain clinical
                       circumstances, such as when a cluster of MRSA mediastinitis
                       or incisional SSI due to methicillin-resistant coagulase-
                       negative staphylococci has been detected. A threshold
                       has not been scientifically defined that can support the
                       decision to use vancomycin in AMP. The decision should
                       involve consideration of local frequencies of MRSA isolates,
                       SSI rates for particular operations, review of infection prevention
                       practices for compliance, and consultation between
                       surgeons and infectious disease experts. An effective SSI
                       surveillance program must be operational, with careful and
                       timely culturing of SSI isolates to determine species and
                       AMP agent susceptibilities.[80]</p>
                     <p>Agents most commonly used for AMP (i.e.,
                       cephalosporins) exhibit time-dependent bactericidal action.
                       The therapeutic effects of such agents are probably maximized
                       when their levels continuously exceed a threshold
                       value best approximated by the minimal bactericidal concentration
                       value observed for the target pathogens in vitro.
                       When the duration of an operation is expected to exceed
                       the time in which therapeutic levels of the AMP agent can
                       be maintained, additional AMP agent should be infused.
                       That time point for cefazolin is estimated as 3 to 4 hours. In
                       general, the timing of a second (or third, etc.) dose of any
                       AMP drug is estimated from three parameters: tissue levels
                       achieved in normal patients by a standard therapeutic
                       dose, the approximate serum half-life of the drug, and
                       awareness of approximate MIC90 values for anticipated SSI
                       pathogens. References in <a href="table6-SSI.html">Table 6</a> should be consulted for
                       these details and important properties of antimicrobial
                       agents used for AMP in various specialties.                       </p>
                     <p>Basic &quot;rules of thumb&quot; guide decisions about AMP
                       dose sizes and timing. For example, it is believed that a full
                       therapeutic dose of cefazolin (1-2 g) should be given to
                       adult patients no more than 30 minutes before the skin is
                       incised.[242,285] There are a few exceptions to this basic guide.
                       With respect to dosing, it has been demonstrated that larger
                       doses of AMP agents are necessary to achieve optimum
                       effect in morbidly obese patients.[293] With respect to timing,
                       an exception occurs for patients undergoing cesarean section
                       in whom AMP is indicated: the initial dose is administered
                       immediately after the umbilical cord is
                       clamped.[266,272,273] If vancomycin is used, an infusion period
                       of approximately 1 hour is required for a typical dose.
                       Clearly, the concept of &quot;on-call&quot; infusion of AMP is flawed
                       simply because delays in transport or schedule changes
                       can mean that suboptimal tissue and serum levels may be
                       present when the operation starts.[242,294] Simple protocols of
                       AMP timing and oversight responsibility should be locally
                       designed to be practical and effective.</p>
                       
                     <p class="topOPage"><a href="004_SSI.html#">Top</a></p>
                     
					  <!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
				  <div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
				
					<!-- InstanceEndEditable -->
						<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
			<!-- /end #content-secondary --></div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>

					<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>May 2, 2011</span></li>
				<li class="last-updated">Page last updated: <span>May 2, 2011</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

			</ul>
		<!-- InstanceEndEditable -->			</div>
	  </div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
siteCatalyst.setLevel4("Guidelines-HICPAC"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
